| Literature DB >> 25870672 |
A M Borcan1, S Huhulescu2, A Munteanu3, A Rafila1.
Abstract
Listeria monocytogenes became an increasing pathogen involved more frequently in sporadic severe illnesses and outbreaks of foodborne infections. This study investigates in vitro susceptibility of 26 strains of Listeria monocytogenes isolated from the clinical specimens collected between March 2009 and November 2013, from 24 patients hospitalized in three medical institutions in Bucharest. All isolates were tested by disk diffusion method to 15 antimicrobial agents, by using disk diffusion tests. Among the 26 clinical L. monocytogenes isolates tested, no multidrug resistant strains were detected, but 18 (72%) were found to be resistant to at least one clinically relevant antibiotic. Among them, 18 clinical isolates were resistant against ciprofloxacin also. Resistance to Ciprofloxacin was particularly noticed to the strains in Romania. Serological and molecular typing by Multiplex PCR method detected two molecular types 1/2 a, 3a and 1/2 b, 3b, as to the more frequent isolated among studied cases. These types of L. monocytogenes could be associated to the higher pathogenic activity of immunodeficient patients.Entities:
Keywords: Listeria monocytogenes; serotyping; severe clinical infection; strains; subtyping
Mesh:
Substances:
Year: 2014 PMID: 25870672 PMCID: PMC4391364
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Origin of the 26 clinical isolates of tested L. monocytogenes
| Origin of isolated strains | No. of strains |
|---|---|
| CSF | 16 |
| Blood-culture | 9 |
| Placenta swab | 1 |
| Total | 26 |
Molecular and antigenic characterization of L. monocytogenes strains
| ID-No. | |||||||||||||||
| C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12a | C12b | C13 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular antigens | HRM-PCR(InIB ST) | ST-2 | ST-16 | ST-2 | ST-15 | ST-2 | ST-30 | ST-30 | ST-9 | ST-9 | ST-2 | ST-1 | ST-15 | ST-15 | ST-15 |
| Typing by Multiplex PCR | 4b,4d,4e | 1/2c,3c | 4b,4d,4e | 1/2a,3a | 1/2a,3a | 1/2a,3a | 1/2a,3a | 1/2a,3a | 1/2a,3a | 4b,4d,4e | 4b,4d,4e | 1/2a,3a | 1/2a,3a | 1/2a,3a | |
| Serotyping by in house agglutination | 4b | 1a | 1a | 1a | 4b | 1a | 1a | 1a | 1a | 4b | 1a | 1a | 1a | 1a | |
| ID-No. | |||||||||||||||
| C14 | C15 | C16 | C17 | C18 | C19 | C20 | C21 | C22 | C23 | C24 | C25 | C26 | |||
| Molecular antigens | HRM-PCR(InIB ST) | ST-15 | ST-1 | ST-8 | ST-2 | ST-1 | ST-1 | ST-8 | ST-2 | ST-15 | ST-30 | ST-9 | ST-8 | ST-16 | |
| Typing by Multiplex PCR | 1/2a,3a | 4b,4d,4e | 1/2a,3a | 4b,4d,4e | 4b,4d,4e | 4b,4d,4e | 1/2a,3a | 4b,4d,4e | 1/2a,3a | 1/2a,3a | 1/2a,3a | 1/2a,3a | 1/2a,3a | ||
| Serotyping by in house agglutination | 1a | 4b | 1a | 1a | 1a | 1a | 1a | 1a | 1a | 1a | 1a | 1a | 1a | ||
| Summarized results of 26 human isolates (including two isolate-pairs from two patients and one mother/child pair). C: human isolates; C12a, C12b: mother/child pair; C6/C7: CSF/blood isolate pair; C8/ C9: CSF/blood isolate pair; InlB ST: Internalin B sequence type. |
Bacterial adherence to Hep-2 cells and virulence factors
| ID-No. | ||||||||||||||
| C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12a | C12b | C13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specimen | CSF | CSF | CSF | CSF | Blood | CSF | Blood | CSF | Blood | CSF | CSF | Blood | Placental swab | CSF |
| nd | nd | nd | nd | Localized aggregative 20% | Diffuse 83% | No adherence | Diffuse 95% | Localized aggregative 20% | nd | Localized aggregative 8% | nd | nd | Diffuse 22% | |
| Virulence factors | nd | nd | nd | nd | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | nd | h,e,c | nd | nd | h,e,c |
| ID-No. | ||||||||||||||
| C14 | C15 | C16 | C17 | C18 | C19 | C20 | C21 | C22 | C23 | C24 | C25 | C26 | ||
| Specimen | CSF | Blood | CSF | CSF | CSF | CSF | CSF | CSF | CSF | CSF | Blood | CSF | CSF | |
| No adherence | Localized aggregative 5% | Localized aggregative 10% | No adherence | Diffuse 20% | Diffuse 5% | Localized aggregative 3% | Diffuse 20% | Localized aggregative 10% | No adherence | Diffuse 22% | No adherence | Localized aggregative 5% | ||
| Virulence factors | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | h,e,c | |
| h: hemolysin; e: esculinase; c: caseinase; li: lipase; nd: not done; CSF: cerebrospinal fluid; **: pregnancy associated; +/-: weak activity |
Antibiotic resistance of 26 L. monocytogenes clinical isolates
| Antibiotic resistance | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of strains | 26 | 26 | 18 | 2 | 2 | 2 | 2 | 1 |
| Serotype | 1/2a, 3a 4b,4d,4e | 1/2a, 3a 4b,4d,4e | 4b,4d,4e 1/2a, 3a | 1/2a, 3a | 1/2a, 3a | 1/2a, 3a | 1/2a, 3a | 4b,4d,4e |